Rutgers / office of Inspector General / Food and Drug Administration / Committee on Clinical Research Involving Children / Institute of Medicine / Government Accountability Office / office of Inspector General Response / Rutgers University Center for Education and Research / Adolescent Psychiatry / Medicare / Administration for Children and Families / American Society of Health System Pharmacists / Department of Health and Human Services OFFICE OF INSPECTOR GENERAL SECOND-GENERATION ANTIPSYCHOTIC DRUG USE AMONG MEDICAID-ENROLLED CHILDREN / American Academy of Child / National Committee for Quality Assurance / American Academy of Child and Adolescent Psychiatry / Medicine (US) Committee / Agency for Healthcare Research and Quality / /
Person
Response / Adolesc / Berman / Field / /
Position
physician / EXECUTIVE / CONCERNS Daniel R. Levinson Inspector General / /
Product
risperidone / States / Antipsychotic Medication / olanzapine / clozapine / fluoxetine / Psychotropic Medication / Federal Food / indications / OEI-07-12 / FDA / /
ProvinceOrState
Texas / Alabama / Maine / Illinois / Indiana / Oregon / New York / Michigan / Missouri / Tennessee / Pennsylvania / Oklahoma / Florida / California / Massachusetts / Colorado / New Hampshire / /